Key result
Acuros XB achieves ~98% dosimetric agreement with Monte Carlo, outperforming the Analytical Anisotropic Algorithm.
Why the study?
Due to the delicate nature of irradiating the heart, dose calculation accuracy is imperative, prompting comparison of calculation algorithms for stereotactic body radiation therapy of ventricular tachycardia.
Does the Acuros XB (AXB) algorithm improve dose calculation accuracy compared to the Analytical Anisotropic Algorithm (AAA) for cardiac radioablation of ventricular tachycardia?
Does the Acuros XB (AXB) algorithm improve dose calculation accuracy compared to the Analytical Anisotropic Algorithm (AAA) for cardiac radioablation of ventricular tachycardia?
The Acuros XB algorithm provides significantly more accurate dose calculations than the Analytical Anisotropic Algorithm for cardiac radioablation of ventricular tachycardia when compared to a Monte Carlo benchmark.
Answers are grounded in this paper and cite their sources.
Consider AXB for dosimetry in cardiac radioablation; extends algorithm validation but leaves open outcome effects.
Ventricular tachycardia is a life-threatening cardiac arrhythmia that can potentially be treated using stereotactic body radiation therapy given as a single fraction. Given these characteristics, along with the delicate nature of irradiating a portion of the heart, accuracy of dose calculation in the treatment planning system is imperative. Two such calculation methods employed are superposition-convolution-based algorithms, such as Varian's Analytical Anisotropic Algorithm (AAA) and Linear Boltzmann Transport Equation solvers, such as Varian's Acuros XB (AXB). The purpose of this work is to compare these calculation algorithms in this treatment setting. Forty-eight patient plans with a nominal planning target volume prescription dose of 25 Gy that were initially calculated using AAA were recalculated using AXB without re-optimization. A third recalculation was conducted using Radformation's standalone Monte Carlo (MC) algorithm as a gold standard. Both AAA and AXB dose distributions were then compared to MC using 3D gamma analysis. Various target dose metrics in the AAA, AXB, and MC plans were compared along with organ-at-risk (OAR) dose points. Relative to MC, the median agreement rate for AAA was 89.1% and for AXB was 98.3%. The minimum agreement rate over the patient cohort was 70.4% and 93.2% for AAA and AXB, respectively. The overall gamma agreement rates were significantly higher for AXB than for AAA. With respect to the target and OAR dose comparisons, in every case, the differences in dose metrics were significantly different between AAA/MC and AXB/MC, with AXB having the superior agreement with MC. The mean differences between MC for both algorithms were lower in each case for AXB. By every metric evaluated, including target dose coverage, OAR dose endpoints, and 3D gamma dose evaluation, AXB resulted in a more precise agreement with the MC dose calculation benchmark for cardiac radioablation of ventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
Prusator et al. (2026) studied Ventricular tachycardia (n=48). Acuros XB (AXB) algorithm vs. Analytical Anisotropic Algorithm (AAA) was evaluated on Median 3D gamma agreement rate relative to Monte Carlo algorithm. The Acuros XB algorithm demonstrated superior dosimetric agreement with the Monte Carlo gold standard compared to the Analytical Anisotropic Algorithm.
Synapse has enriched 10 related papers. Consider them for comparative context: